Proteomics uncover EPHA2 as a potential novel therapeutic target in colorectal cancer cell lines with acquired cetuximab resistance
Dokumenttyp:
Zeitschriftenaufsatz
Autor(en):
Torlot, Lucien ; Jarzab, Anna ; Albert, Johanna ; Pók-Udvari, Ágnes ; Stahler, Arndt ; Holch, Julian Walter ; Gerlinger, Marco ; Heinemann, Volker ; Klauschen, Frederick ; Kirchner, Thomas ; Kumbrink, Jörg ; Küster, Bernhard ; Jung, Andreas
Stichworte:
Original Article - Cancer Research ; Colorectal cancer ; EPHA2 ; Cetuximab resistance ; Molecular oncology ; Proteomics ; Medical and Health Sciences